Literature DB >> 2354545

Liposomes composed of partially hydrogenated egg phosphatidylcholines: fatty acid composition, thermal phase behavior and oxidative stability.

J Lang1, C Vigo-Pelfrey, F Martin.   

Abstract

Partially hydrogenated egg phosphatidylcholines (PHEPC) represent a new class of raw materials for liposome-based drug products. PHEPC were manufactured from native egg phosphatidylcholine (EPC) to iodine values (IV) 40, 30, 20, 10, and 1. Hydrogenation resulted in a complete loss of arachidonic acid (20:4) and docosahexaenoic acid (22:6) in IV 40 EPC and a progressive conversion of linoleic (18:2) and oleic acid (18:1) to stearic acid (18:0) at higher degrees of hydrogenation (IV 30, 20, 10, 1). Hydrogenation lead to formation of trans-fatty acid isomers maximally 18.5 mol% in IV 20 EPC. Liposomes made from IV 20, IV 10 and IV 1 EPC had marked phase transitions between 20 and 60 degrees C. PHEPC showed increased resistance to oxidation as measured by oxygen uptake during 2,2'-azobis-(2-amidinopropane) hydrochloride (AAPH) initiated accelerated oxidation. Various applications of these new materials in the manufacture of liposomes and liposome based drug products are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2354545     DOI: 10.1016/0009-3084(90)90137-g

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  4 in total

1.  Technetium-99m labelled liposomes to image experimental arthritis.

Authors:  O C Boerman; W J Oyen; G Storm; M L Corvo; L van Bloois; J W van der Meer; F H Corstens
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

2.  Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential.

Authors:  M C Woodle; L R Collins; E Sponsler; N Kossovsky; D Papahadjopoulos; F J Martin
Journal:  Biophys J       Date:  1992-04       Impact factor: 4.033

Review 3.  Oxidative stress in toxicology: established mammalian and emerging piscine model systems.

Authors:  K A Kelly; C M Havrilla; T C Brady; K H Abramo; E D Levin
Journal:  Environ Health Perspect       Date:  1998-07       Impact factor: 9.031

4.  A comparative evaluation of a novel vaccine in APP/PS1 mouse models of Alzheimer's disease.

Authors:  Iván Carrera; Ignacio Etcheverría; Lucía Fernández-Novoa; Valter Ruggero Maria Lombardi; Madepalli Krishnappa Lakshmana; Ramón Cacabelos; Carmen Vigo
Journal:  Biomed Res Int       Date:  2015-02-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.